NICE yatanze inama ku nshuro ya mbere y’ubuvuzi bushya bushobora gufasha impinja, abana n’urubyiruko ruri kuvurwa kanseri kwirinda gutakaza ubushobozi bwo kumva.
Cisplatin ni umuti ukomeye wa chimiotherapie ukoreshwa cyane mu kuvura ubwoko bwinshi bwa kanseri y’abana. Uko igihe kigenda gihita, cisplatin ishobora kwirundanya mu gutwi imbere igatera ububyimbirwe n’ibyangiritse bizwi nka ototoxicity, ari na yo mpamvu imwe mu mpamvu zitera kubura amatwi.
Ibyifuzo bya nyuma by’umushinga bitanga inama yo gukoresha sodium thiosulfate idafututse, izwi kandi nka Pedmarqsi ikaba ikorwa na Norgine, mu rwego rwo gukumira ububabare bwo kutumva buterwa na chimiotherapie ya cisplatin ku bana bari hagati y’ukwezi 1 n’imyaka 17 bafite ibibyimba bikomeye bitarakwirakwira mu bindi bice by’umubiri.
Abana bagera kuri 60% bavuwe na cisplatin bazarwara indwara yo kutumva burundu, aho abana bari munsi y'imyaka 18 bavuwe mu Bwongereza hagati ya 2022 na 2023 bashya 283 bafite ikibazo cyo kutumva cyatewe n'uburozi bwo mu mutwe.
Uyu muti, utangwa nk'umuforomo cyangwa umuganga, ukora mu gufatana na cisplatin itarafatwa n'uturemangingo no kubuza imikorere yayo, bityo bikarinda kwangirika kw'uturemangingo tw'amatwi. Gukoresha sodium thiosulfate anhydrous ntibigira ingaruka ku mikorere ya chimiotherapie ya cisplatin.
Bivugwa ko mu mwaka wa mbere w’inama yo gukoresha sodium thiosulfate idafite amazi, abana n’urubyiruko bagera kuri miliyoni 60 mu Bwongereza bazaba bemerewe guhabwa uyu muti.
Gutakaza ubushobozi bwo kumva bitewe no kuvura kanseri bishobora kugira ingaruka mbi ku bana n'imiryango yabo, bityo twishimiye kuba twakugira inama yo kuvura indwara zitandukanye.
Uyu ni wo muti wa mbere wagaragaye ko urinda kandi ukagabanya ingaruka zo kutumva kandi uzagira ingaruka zikomeye ku buzima bw'abana n'urubyiruko.
Helen yakomeje agira ati: “Impamyabumenyi yacu y’ubu buvuzi bushya igaragaza ko NICE yiyemeje kwibanda ku by’ingenzi kurusha ibindi: gutanga ubuvuzi bwiza ku barwayi vuba no kwemeza ko amafaranga yabo ahabwa agaciro.”
Amakuru yavuye mu bushakashatsi bubiri bw’ubuvuzi yagaragaje ko ubu buryo bwo kuvura bwagabanyije hafi kimwe cya kabiri igipimo cy’abana batakaje ubushobozi bwo kutumva mu gihe cy’abana bahawe imiti ya chiplatin. Igerageza rimwe ryagaragaje ko abana bahawe imiti ya chiplatin ikurikirwa na sodium thiosulfate ya anhydrous bari bafite igipimo cya 32.7% cy’ububabare bwo kutumva, ugereranyije n’igipimo cya 63% cy’abana bahawe imiti ya chiplatin gusa.
Mu bundi bushakashatsi, 56.4% by'abana bahabwaga cisplatin bonyine bahuye n'ikibazo cyo kutumva, ugereranije na 28.6% by'abana bahabwaga cisplatin hagakurikiraho anhydrous sodium thiosulfate.
Igeragezwa ryagaragaje kandi ko iyo abana bagiraga ikibazo cyo kutumva, muri rusange byabaga bito cyane ku bakoreshaga sodium thiosulfate idakora neza.
Ababyeyi babwiye komite yigenga ya NICE ko niba umuntu afite ikibazo cyo kutumva bitewe na chimiotherapie ya cisplatin, bishobora kugira ingaruka ku mivugire n'iterambere ry'ururimi, ndetse no ku mikorere ye ku ishuri no mu rugo.
Twishimiye gutangaza ko uyu muti w’ingirakamaro uzakoreshwa ku barwayi bakiri bato bari kuvurwa kanseri kugira ngo hirindwe ingaruka mbi za chimiotherapie ya cisplatin.
Ralph yakomeje agira ati: “Twiteze kubona uyu muti mu bitaro hirya no hino mu gihugu kandi twizeye ko abana bose bashobora kuwubyaza umusaruro vuba bazashobora kubona ubu buryo bwo kurokora ubuzima. Turashimira abadushyigikiye ku bw'umusanzu wabo, byatumye RNID itanga ibitekerezo by'ingenzi n'ibimenyetso byo gufasha kugira ngo uyu muti uboneke cyane mu Bwongereza. Ni ubwa mbere umuti ukozwe by'umwihariko kugira ngo wirinde indwara yo kutumva kandi ukaba usabwa gukoreshwa muri NHS. Iki ni igikorwa cy'ingenzi kizaha abashora imari mu kuvura indwara yo kutumva icyizere cy'uko bashobora kuzana umuti ku isoko.”
Ubu buvuzi buzaboneka kuri NHS mu Bwongereza mu mezi atatu uhereye igihe amabwiriza ya nyuma ya NICE asohowe.
Iyi kompanyi yagiranye amasezerano y’ubucuruzi mu ibanga yo gutanga sodium thiosulfate idafunze ku rwego rw’igihugu rw’ubuzima ku giciro gito.